Oslo, 11 August 2021: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage
leader in immune stimulatory vaccines for cancer, invites to a webcast
presentation of its second quarter 2021 results on Friday 20 August 2021.
The presentation can be followed as a live webcast (access through link
https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20210820_5) at 09:00
CET on Friday 20 August 2021. The webcast presentation will be available on the
Ultimovacs website, and it will be possible to post questions during the
presentation through the webcast.
The report and presentation will be available on the company website from 08:00
CET the same day.
For further information, please see www.ultimovacs.com
(http://www.ultimovacs.com) or contact:
Carlos de Sousa, CEO
Email: carlos.desousa@ultimovacs.com (mailto:carlos.desousa@ultimovacs.com)
Phone: +47 908 92507
Hans Vassgård Eid, CFO
Email: hans.eid@ultimovacs.com (mailto:hans.eid@ultimovacs.com)
Phone: +47 482 48632
Mary-Ann Chang, LifeSci Advisors
Email: mchang@lifesciadvisors.com (mailto:mchang@lifesciadvisors.com)
Phone: +44 7483 284 853